Your browser doesn't support javascript.
loading
Dexmedetomidine in pulmonary hypertension: a Review
Anaesthesia, Pain and Intensive Care. 2013; 17 (3): 279-281
en Inglés | IMEMR | ID: emr-164417
ABSTRACT
Patients with pulmonary hypertension often have adverse outcomes after anesthesia. Tachycardia, hypertension, hypervolemia, increased intrathoracic pressure, acidosis, painful stimuli and hyperthermia are triggering factors for adverse perioperative events. Dexmedetomidine is a centrally acting alpha agonist which, due to its desirable properties like sympatholysis, bradycardia and micro agonism, can be a useful agent for patients with pulmonary hypertension. Dexmedetomidine also has the ability to potentiate inhalational, intravenous and regional anesthetics when it is used as an adjunct
Buscar en Google
Índice: IMEMR (Mediterraneo Oriental) Idioma: Inglés Revista: Anaesth. Pain Intensive Care Año: 2013

Similares

MEDLINE

...
LILACS

LIS

Buscar en Google
Índice: IMEMR (Mediterraneo Oriental) Idioma: Inglés Revista: Anaesth. Pain Intensive Care Año: 2013